Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Telstar Provides Safety Cabinets to NUI Galway’s Biomedical Research Facility

Published: Wednesday, March 19, 2014
Last Updated: Wednesday, March 19, 2014
Bookmark and Share
The new, recently inaugurated research facility, which is directed towards cancer research, regenerative medicine and glycosciences, takes its place as one of five global hubs in the medtech sector.

A complete package comprising 63 cabinets developed by Telstar has been delivered to the new Biomedical Science Research Facility at the National University of Ireland in Galway (NUI Galway).

The activities of NUI Galway’s Biomedical Science Research Facility are specifically directed towards cancer research, regenerative medicine and glycosciences.

The cabinets provided by Telstar have been designed considering specific bioprocessing applications in the medical and clinical research field.

The suite of cabinets provided by Telstar represent a new generation of innovative biological safety cabinets designed to work in research environments such as tissue culture suites, radiochemistry, flow cytometry, screening core, sample preparation and biomimic areas.

The cabinets developed by Telstar for NUI Galway’s Biomedical Science Research Facility are more compact and optimize the usable work area in laboratories with limited space.

The cabinet design offers a body 20% smaller than the market average while maintaining standard work space.

Intended for the laminar flow manipulation of microorganisms with biological risk levels 2 and 3, the new range of Telstar safety cabinets offers an ergonomic design that adapts easily to small spaces, especially in laboratories with low ceilings and where several pieces of equipment need to be used in the same area.

Of the total of cabinets designed by Telstar, 57 of them correspond to Telstar Bio II Advance range, the class II cabinet designed in accordance EN12469 standard, and 6 units of EF B range of class II B2 cabinets in accordance with NSF49 standard.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Speeding Up the Process of Making Vaccines
System uses a freeze-dry concept to develop "just-add-water" solution.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos